R.H. Dinel Investment Counsel, Inc. Merck & Co., Inc. Transaction History
R.H. Dinel Investment Counsel, Inc.
- $154 Million
- Q2 2024
A detailed history of R.H. Dinel Investment Counsel, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, R.H. Dinel Investment Counsel, Inc. holds 52,602 shares of MRK stock, worth $6.2 Million. This represents 4.23% of its overall portfolio holdings.
Number of Shares
52,602
Previous 58,377
9.89%
Holding current value
$6.2 Million
Previous $7.7 Million
15.45%
% of portfolio
4.23%
Previous 5.05%
Shares
6 transactions
Others Institutions Holding MRK
# of Institutions
3,825Shares Held
1.91BCall Options Held
13.4MPut Options Held
10.7M-
Vanguard Group Inc Valley Forge, PA245MShares$28.8 Billion0.59% of portfolio
-
Black Rock Inc. New York, NY207MShares$24.4 Billion0.59% of portfolio
-
State Street Corp Boston, MA117MShares$13.8 Billion0.65% of portfolio
-
Wellington Management Group LLP Boston, MA72.5MShares$8.54 Billion1.64% of portfolio
-
Geode Capital Management, LLC Boston, MA57MShares$6.72 Billion0.63% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $299B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...